TrialCancer2018

Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: A single-arm phase 2 clinical trial.

Kathryn A Gold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.